If you look at the shareprice you will realise that SAMR is not going to be granted anytime soon. That's why it's a good buy right now!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025